Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Market Size Estimates For The Mitral Valve Disease Market?

In recent times, the mitral valve disease market has experienced significant growth. The market size is projected to increase from $3 billion in 2024 to $3.28 billion in 2025, with a compound annual growth rate (CAGR) of 9.1%. The significant growth during the historic period can be attributed to factors such as patient education initiatives, sufficient reimbursement policies and insurance coverage, the growth in healthcare spending, increased awareness and screening endeavors, and a widening market presence.

The market for mitral valve disease is projected to experience substantial expansion in the coming years, with predictions placing it at $4.65 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.2%. This growth for the forecast interval is potentially due to a number of factors including an increased incidence of mitral valve disease, a growing preference for minimally invasive methods, significant advancements in heart valve surgery, increased venture capital funding, and a heightened focus from manufacturers. Prominent trends for the projected period encompass technological progression, developments in transcatheter technologies, and continual advancements in surgical procedures.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16480&type=smp

Which Industry Forces Are Driving The Mitral Valve Disease Market Forward?

The mitral valve disease market is projected to expand due to the rising incidents of vascular heart diseases. These diseases, which affect the heart’s blood vessels or the heart itself, are becoming more common due to a mix of lifestyle factors, demographic shifts, specific medical conditions, environmental influences and genetic factors. Ischemic heart disease and hypertension are examples of vascular heart diseases that can indirectly lead to mitral valve disease by damaging the structure and function of the heart, causing conditions that affect the mitral valve. For example, data from the Australian Bureau of Statistics 2020-21 and the Australian Institute of Health and Welfare reveals that there was a rise in the mortality rate due to cardiovascular disease per 100,000 population in Australia, from 143.7 in 2021 to 148.2 in 2022 among males. This surge in vascular heart diseases is therefore contributing to the growth of the mitral valve disease market.

How Is The Mitral Valve Disease Market Organized By Different Segments?

The mitral valve diseasemarket covered in this report is segmented –

1) By Treatment Type: Mitral Valve Repair; Mitral Valve Replacement; Cardiac Resynchronization Therapy; Mitral Valve Therapeutics

2) By Indication: Mitral Valve Stenosis; Mitral Valve Prolapse; Mitral Valve Regurgitation

3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users

Subsegments:

1) By Mitral Valve Repair: Surgical Repair; Minimally Invasive Repair; Percutaneous Mitral Valve Repair

2) By Mitral Valve Replacement: Mechanical Valve Replacement; Biological Valve Replacement; Transcatheter Mitral Valve Replacement (TMVR)

3) By Cardiac Resynchronization Therapy: Pacemaker Therapy; Implantable Cardioverter-Defibrillators (ICD); Biventricular Pacing

4) By Mitral Valve Therapeutics: Pharmacological Treatments; Anticoagulation Therapy; Mitral Valve Repair Devices

What Key Trends Are Driving Growth In The Mitral Valve Disease Market?

Key enterprises in the mitral valve disease market are making strides in the development of stented tissue valves, in response to a rising demand for less invasive medical treatments. Stented tissue valves are designed to offer both durability and reliability, providing an alternative solution to patients who would otherwise undergo traditional surgeries. For example, Medtronic, a healthcare corporation based in Ireland, introduced its Avalus Ultra valve in April 2024. This advanced surgical aortic tissue valve aims to improve the implantation process and long-term patient care. Leveraging a decade’s worth of clinical knowledge from its precursor, the original Avalus valve, the Avalus Ultra boasts a low valve profile for smooth implantation, a PEEK base frame to maintain consistency in circularity, and an industry-topping Effective Orifice Area (EOA) to potentially improve blood circulation. Furthermore, the Avalus Ultra comes with a radiopaque coil for superior visibility in future valve-in-valve procedures.

Who Are The Primary Market Leaders In The Mitral Valve Disease Market?

Major companies operating in the mitral valve disease market are Pfizer Inc., Bayer AG, Abbott Laboratories, Novartis AG, Medtronic plc, Boston Scientific Corporation, Edwards Lifesciences, ShockWave Medical Inc., Artivion Inc., TTK Health Care Limited, Braile Biomedica, JenaValve Technology Inc., 4C Medical technologies, Labcor Laboratorios Ltda, CryoLife Inc., Valcare Medical, Affluent Medical, Colibri Heart Valve LLC, Coramaze Technologies, Corcym UK Limited, HighLife Medical, Micro International Devices Inc., Neovasc Inc., Mitralign Inc., Transcatheter Technologies GmbH

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/mitral-valve-disease-global-market-report

How Do Regional Dynamics Influence The Mitral Valve Disease Market Performance?

Europe was the largest region in the mitral valve disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mitral valve disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16480&type=smp

Browse Through More Reports Similar to the Global Mitral Valve Disease Market 2025, By The Business Research Company

Vacuum Valve Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/vacuum-valve-global-market-report

Aerospace Valves Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/aerospace-valves-global-market-report

Pigging Valves Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pigging-valves-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model